Clinical trial NCT01722214 - References

Psoriasis — Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Psoriasis

Citation(s)

•   Ahlehoff O, Gislason GH, Lindhardsen J, Olesen JB, Charlot M, Skov L, Torp-Pedersen C, Hansen PR
  Prognosis following first-time myocardial infarction in patients with psoriasis: a Danish nationwide cohort study. J Intern Med. 2011 Sep;270(3):237-44. doi: 10.1111/j.1365-2796.2011.02368.x. Epub 2011 Mar 24.
•   Davidovici BB, Sattar N, Prinz J, Puig L, Emery P, Barker JN, van de Kerkhof P, Ståhle M, Nestle FO, Girolomoni G, Krueger JG
  Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol. 2010 Jul;130(7):1785-96. doi: 10.1038/jid.2010.103. Epub 2010 May 6. Review. Erratum in: J Invest Dermatol. 2010 Oct;130(10):2517. Jörg, Prinz C [corrected to Prinz, Jörg C].
•   Dixon WG, Symmons DP
  What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology. Ann Rheum Dis. 2007 Sep;66(9):1132-6. Epub 2007 Jan 24. Review.
•   Dixon WG, Watson KD, Lunt M, Hyrich KL; British Society for Rheumatology Biologics Register Control Centre Consortium, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register
  Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum. 2007 Sep;56(9):2905-12.
•   Fredriksson T, Pettersson U
  Severe psoriasis--oral therapy with a new retinoid. Dermatologica. 1978;157(4):238-44.
•   Gelfand JM, Dommasch ED, Shin DB, Azfar RS, Kurd SK, Wang X, Troxel AB
  The risk of stroke in patients with psoriasis. J Invest Dermatol. 2009 Oct;129(10):2411-8. doi: 10.1038/jid.2009.112. Epub 2009 May 21.
•   Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB
  Risk of myocardial infarction in patients with psoriasis. JAMA. 2006 Oct 11;296(14):1735-41.
•   Hansson GK
  Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005 Apr 21;352(16):1685-95. Review.
•   Jacobsson LT, Turesson C, Gülfe A, Kapetanovic MC, Petersson IF, Saxne T, Geborek P
  Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J Rheumatol. 2005 Jul;32(7):1213-8.
•   Ko H-S, M
  D. Medical Officer, Division of Dermatologic and Dental Drug Products, Center for Drug Evaluation and Research, Food and Drug Administration, Bethesda MD. Clinical Design for Psoriasis [presentation]. Dermatologic and Ophthalmic Drugs Advisory Committee 49th Meeting Open Session (Volume II); Gaithersburg, MD. 1998 March 20.
•   Marks R, Barton SP, Shuttleworth D, Finlay AY
  Assessment of disease progress in psoriasis. Arch Dermatol. 1989 Feb;125(2):235-40. Review.
•   Mehta NN, Yu Y, Saboury B, Foroughi N, Krishnamoorthy P, Raper A, Baer A, Antigua J, Van Voorhees AS, Torigian DA, Alavi A, Gelfand JM
  Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study. Arch Dermatol. 2011 Sep;147(9):1031-9. doi: 10.1001/archdermatol.2011.119. Epub 2011 May 16.
•   Miyasaka Y, Barnes ME, Petersen RC, Cha SS, Bailey KR, Gersh BJ, Casaclang-Verzosa G, Abhayaratna WP, Seward JB, Iwasaka T, Tsang TS
  Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a community-based cohort. Eur Heart J. 2007 Aug;28(16):1962-7. Epub 2007 Apr 25.
•   Moubayed SP, Heinonen TM, Tardif JC
  Anti-inflammatory drugs and atherosclerosis. Curr Opin Lipidol. 2007 Dec;18(6):638-44. Review.
•   Prodanovich S, Kirsner RS, Kravetz JD, Ma F, Martinez L, Federman DG
  Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol. 2009 Jun;145(6):700-3. doi: 10.1001/archdermatol.2009.94.
•   Turesson C, McClelland RL, Christianson TJ, Matteson EL
  Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis. 2007 Jan;66(1):70-5. Epub 2006 Jul 28.
•   van Leuven SI, Franssen R, Kastelein JJ, Levi M, Stroes ES, Tak PP
  Systemic inflammation as a risk factor for atherothrombosis. Rheumatology (Oxford). 2008 Jan;47(1):3-7. Epub 2007 Aug 16. Review.
•   Wu F
  The effect of tumor necrosis factor-alfa inhibitors on the risk of myocardial infarction in patients with psoriasis. E-poster session presented at the 69th American Academy of Dermatology, Abstract P400; 4-8 Feb 2011; New Orleans, USA.

Randomized Multicenter Placebo-controlled Trial on the Effect of Adalumumab on Vascular Inflammation in Patient With Moderate to Severe Psoriasis

Details for clinical trial NCT01722214